cis-Diammineplatinum(II) dichloride
SIGMA/P4394 - crystalline
Synonym: cis-Dichlorodiammine platinum(II); cis-Platinum(II) diammine dichloride; Cisplatin
CAS Number: 15663-27-1
Empirical Formula (Hill Notation): H6Cl2N2Pt
Molecular Weight: 300.05
EC Number: 239-733-8
MDL Number: MFCD00011623
Linear Formula: Pt(NH3)2Cl2
Product Type: Chemical
| antibiotic activity spectrum | neoplastics |
| color | yellow |
| form | crystalline |
| InChI | 1S/2ClH.2H3N.Pt/h2*1H;2*1 |
| InChI key | LXZZYRPGZAFOLE-UHFFFAOYSA |
| mode of action | DNA synthesis | interferes |
| mp | 270 °C (lit.) |
| originator | Corden |
| Quality Level | 200 ![]() |
| SMILES string | N.N.Cl[Pt]Cl |
| Application: | cis-Diammineplatinum(II) dichloride has been used: • in cell viability measurement in cochlear explants • in the inhibition of cell proliferation and chemosensitivity in ovarian cancer cell lines • in MTT [3-(4,5-Dimethylthiazol-2 |
| Biochem/physiol Actions: | Potent chemoimmunotherapeutic drug; stimulates the immune responses by activating macrophages and other cells of the immune system. Cisplatin-treated macrophages show increased antigen presentation function in vitro. Treatment increased cellular NF-κB content and translocation in macrophages. Cisplatin effects are regulated by kinases, phosphatases, and Ca2+/calmodulin. Forms cytotoxic adducts with the DNA dinucleotide d(pGpG), inducing intrastrand crosslinks. |
| Biochem/physiol Actions: | Potent platinum-based antineoplastic agent. Forms cytotoxic adducts with the DNA dinucleotide d(pGpG), inducing intrastrand cross-links. |
| Features and Benefits: | This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the Caspases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Corden . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1 g in glass bottle |
| Packaging: | 100, 250 mg in glass bottle |
| Packaging: | 25 mg in glass insert |
| Preparation Note: | This product is to be stored in room temperature. Keep the product tightly closed in a well-ventilated place. Dry. Please view the Safety Data Sheet for more information. |
| Symbol | ![]() GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H300 - H315 - H317 - H319 - H334 - H335 - H350 |
| Precautionary statements | P201 - P280 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 45-25-41 |
| Safety Statements | 53-26-39-45 |
| RIDADR | UN 3288 6.1 / PGII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 270 °C (lit.) |
| UNSPSC | 12352200 |



